Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 1 of 1 found. | Sort by relevance

1 Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study
article 1999    
Author: Valk-de Roo, G.W. de · Stehouwer, C.D.A. · Meijer, P. · Mijatovic, V. · Kluft, C. · Kenemans, P. · Cohen, F. · Watts, S. · Netelenbos, C.
Keywords: Biology · Coagulation · Estrogen · Fibrinolysis · Lipids · Raloxifene · C reactive protein · Biological Markers · Blood Coagulation · Blood Pressure · C-Reactive Protein · Carbohydrate Metabolism · Coronary Disease · Double-Blind Method · Estrogen Antagonists · Estrogens · Female · Fibrinolysis · Hormone Replacement Therapy · Humans · Hysterectomy · Middle Aged · Placebos · Postmenopause · Raloxifene · Risk Factors
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 1 of 1 found. | Sort by relevance